Exelixis
EXEL
#1637
Rank
A$16.32 B
Marketcap
$58.35
Share price
-0.38%
Change (1 day)
59.49%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $78.30 AUD on 2000-07-26

Lowest end of day price: $2.05 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$61.59 0.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
$88.74 1.66%๐Ÿ‡ซ๐Ÿ‡ท France
$141.86 1.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$95.42 1.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$487.99 0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$260.27 0.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$40.08 0.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.69-3.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.85 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA